(secondQuint)Study of Alwextin Cream in Treating Epidermolysis Bullosa.

 Potential subjects came to the for a screening visit.

 Eligible subjects had baseline assessments performed and were provided study medication, allantoin 3% cream.

 Subjects were instructed to apply the study medication to the entire body once daily and to keep daily record of study medication use.

 Subjects returned every 4 weeks for a total of 12 weeks for repeat assessments.

.

 Study of Alwextin Cream in Treating Epidermolysis Bullosa@highlight

The purpose of this study is to determine how safe and effective allantoin 3% cream (Alwextin) is in improving the healing of recurrent skin lesions and reducing overall blistering in people with epidermolysis bullosa (EB).

 Allantoin 3% cream is applied topically to the entire body once daily.

